收藏 分销(赏)

内科学DisordersofDigestiveSys.docx

上传人:xrp****65 文档编号:8181790 上传时间:2025-02-06 格式:DOCX 页数:23 大小:2.82MB 下载积分:10 金币
下载 相关 举报
内科学DisordersofDigestiveSys.docx_第1页
第1页 / 共23页
内科学DisordersofDigestiveSys.docx_第2页
第2页 / 共23页


点击查看更多>>
资源描述
Disorders of Digestive System Basic structure of digestive system w Gastrointestinal tract w Histologic organization anatomy and physiology of STOMACH zonation of stomach • cardia • fundus • body • antrum w Receptor of parietal cell Acetylcholine w Receptors of hypersecretion Gastrin Histamine Prostaglandins w Receptors of hyposecretion Somatostatin w Histologic organization of the GI tract epithelium mucosa lamina propria muscularis mucosae wall of the GI submucosa muscularis inner circular layer outer longitudinal layer serosa w Digestive glands • liver : complex function • pancreas : endocrine:insulin two functions trypsin exocrine: amylopsin steapsin • biliary systeme LIVER Double blood supply Portal vein 75% Hepatic artery 25% lobules of liver fundamental unit of the liver Other associated organs • peritoneum • mesentery • omentum Function of the Digestive System w Digestion w Absorption w Metabolism w Excretion w Endocrine w Digestion: digestion refers to the conversion of ingested food molecules into smaller capable of being absorbed into the blood and lymph. w Absorption: Absorption refers to the process of absorbable molecules entering the blood or lymph. active transportation absorptive mechanisms simple diffusion facilitated diffusion endocytosis long-chain fatty acid →lymph monoglycerides other nutrients ───→blood w Metabolism of liver biochemical processes absorbed nutrients are primarily managed toxins are detoxicated hormones are inactiveted w Excretion: bilirubin, cholesterine and some drugs are excreted by the liver. w Endocrin: endocrine cells in the stomach, intestine, and pancreas. They can secret a lot of hormones. • Till now, morn than twenty hormones have been found in the digestive system. • The number of hormone produced by the digestive system is increasing. • The hormones produced by GI tract not only modulate the activity of digestive system but also play an important role in the regulation of a lot of other physiological functions. • In recent years, it is found that GI tract can produce a number of peptide hormones. • This peptide hormones previously found to be produced by the brain. • These peptides are named as`brain-gut peptides ` Diagnostic measures w History and symptoms w Physical examination(sign) w Laboratory symptoms and common diseases w History: History taking can provide very important information. For some digestive diseases only by these means can be established accurate diagnoses . Acute gastritis Acute appendicitis 1、esophagus History and symptoms chest pain dysphagia heart burn acid reflux Common disease esophagitis 、GERD、esophageal carcinoma、achalasia of cardia 2、stomach and duodenum History and symptoms epigastric pain anorexia nausea 、vomiting belch、acid regurgitation Common disease acute and chronic gastritis 、peptic ulcer、gastric carcinoma、functional dyspepsia 3、intestine History and symptoms abdominal pain diarrhea malnutrition Common disease chordapsus 、intestinal tuberculosis 、Crohn disease 4、colon and rectum History and symptoms abdominal pain diarrhea、constipation rectal tenesmus Common disease Dysentery 、ulcerative colitis 、irritable bowel syndrome、carcinoma of large intestine 5、liver History and symptoms complaint or pain of hepatic region hepatauxe tenderness of hepatic region portal hypertension jaundice hepatic encephalopathy nutrition dysmetabolism Common disease viral hepatitis、cirrhosis、primary hepatic carcinoma。 6、bill duct History and symptoms abdominal pain jaundice murphy’s sign Common disease cholelithiasis、cholecystitis、biliary tractroundworm、 biliary tract tumor 7、pancreas History and symptoms epigastric pain secretion disorder of pancreas external secretion:Intestinal malabsorption internal secretion: metabolic disorder Common disease acute、chronic pancreatitis pancreatic carcinoma 8、peritoneum、mesentery History and symptoms abdominal pain abdominal tenderness、rebound tenderness、abdominal guarding (triad) ascites Common disease peritonitis, mesenteric lymphadenitis, tuberculosis, metastatic carcinoma of abdominal membrane Common symptoms • anorexia • nausea • vomiting • acid regurgitation • belching • heart-burn • dysphagia • Abdominal distention • diarrhea • abdominal pain • constipation • hematemesis • melena • hematochezia Physical examination w common signs • abdominal shape • peristaltic rushes • abdominal varices and the direction of blood flow • abdominal tenderness and the location • rebound tenderness • abdominal guarding • shifting dullness • Bowel sounds • abdominal mass • jaundice • hepatomegaly • splenomegaly Laboratory tests • stool tests • acid secretion test • hepatic function tests Imaging procedures • plain film • barium meal and barium enema • ultrasonagraphy • computed tomography, CT • endoscopic retrograde cholangiopancreatogyaphy, ERCP • magnetic resonance imaging, MRI w Endoscopy • gastroscopy • colonoscopy • laparoscopy others Ø biopsy Ø motion function Ø laparotomy Prevention and Treatment of digestive diseases w Prophylaxis w systemic treatment w psychological treatment w comprehensive measure medication surgery traditional chinese medicine general treatment ⒈ resting ⒉ noruishment(drink and food) ⒊ Supportive treatment pharmacotherapy ⒈treatment for causes and pathogenesis ⒉symptomatic treatment surgical or interventional treatment indications w points for attention contraindications side effects Advances and Forecast 1. medication of peptic ulcer 2. diagnose and treatment of digestive malignancy 3. management of portal hypertension 4. diagnose and treatment of alimentary tract hemorrhage 5. clinical application of digestive endoscopy 6. interventional treatment Gastritis Definition w Defect of gastric mucosa :damage, inflammation, regeneration w Gastritis refers to the inflammation of gastric mucosa. w gastropathy w Is a common disease. classification According to the clinical process and pathology, gastritis is classified into : w 1.acute(erosive/hemorrhagic ) gastritis w 2. Chronic gastritis w 3.special gastrtis (corrosive gastritis, suppurative gastritis) ACUTE GASTRITIS Definition : • acute gastritis mainly refers to acute erosive/hemorrhagic of gastric mucosa • Other name: acute erosive and hemorrhagic gastritis , acute gastric mucosal lesion • Endoscopy: hyperemia, edema, hemorrhage, erosive, superficial ulcer • pathology: diffuse or localized superficial erosive that do not extent deeper than muscularis mucosae • the erosive may cause bleeding that range from occult blood loss to massive bleeding. Classification: • acute erosive and hemorrhagic gastritis • acute corrosive gastritis • acute suppurative gastritis Etiology and pathophysiology infectious factors External factors chemical factors(NSAID) physic factors stress (more common) Internal factors bile reflux vascular factors 1 .chemical damage • Drugs : non-steroid anti-inflammatory drugs, NSAIDs – Aspirin, Paracetmol, Indometacin, Dicloeenac, Sodium ect • Ethanol • Strong tea • coffee 2. Stress: • severe surgical trauma – multi-fracture, severe trauma, burning trauma (curhing ulcer), brain trauma (cushing ulcer) • medical conditions – respiratory failure, renal failure, cardiac function failure 3. acute bacteria inflammation: • toxin • bacteria 4. Bile and pancreatic juice reflux • principally following surgery (pylorus is taken away) • pyloric dysfunction 5. other factors • ischemia • radiation • ingestion of alkali (NaHCO3) / acid (sulphuric acid, hydrochloric acid) Mechanism • The mechanisms of mucosal injury are not very clear • The damage of mucus /mucosal barrier is consider to be the key procedure resulting in acid back diffusion and mucosal injury caused by gastric mucosal ischemia . • NSAIDs and ethanol can inhibit cyclooxyenase (COX) and reduce endogenous prostaglandins (PGs) in gastric mucosa . PGs: increase gastric mucosal blood flow; enhance the renewal of gastric mucosa ; increase the secretion of gastric mucus. • Since endogenous PGs play an important role in the maintenance of the mucosal integrity, decrease of endogenous PGs can cause mucosal damage. • Stress may cause reduction of mucosal blood supply or damage of other defensive mechanisms. Some stress factors may also cause gastric acid oversecretion. • Bile salts and pancreatic enzymes decompose mucus and break biological membrane. These mechanism can all result in mucosal injury and erosion. Pathology ⒈diseased region:gastric antrum、gastric body or to fill with whole stomach. ⒉pathological changes:hyperemia、oedema、erosio、hemorrhage、superficial ulceration with gastric mucosa . Characteristics of histology ⒈Inflammatory cell infiltrate of lamina propria mucosae; ⒉Deprivation and hemorrhage of epithelial cells; ⒊ Distort and effusion of gland in mucosa. Clinical feature w Bleeding • many cases of acute gastritis are insidious (asymptomatic or be covered up by other medical conditions ), so lead to escape diagnosis • in some cases, massive bleeding occurs and some times the bleeding may be vital • generally,the bleeding is self-limited w Other symptoms : apigastric pain nausea vomiting indigestion diarrhea w Signs: slight tenderness in epigastrium Diagnosis w History: w Symptoms: w definitive diagnosis: endoscopic exam . generally, the acute endoscopic examination should be performed within 24~48 hours after the bleeding. w Endocopy: hyperemia petechia hemorrhage erosions superficial ulceration w These changes may be diffuse or limited to the antrum , fundus or body. w In the strictest sense, the diagnosis of acute gastritis should be made by pathologists from the histopathologic findings of the biopsy specimen. • Inflammatory cells(usually neutrophils and mononuclear cells) infiltrate the lamina propria, where the glandular areas are distorted by edema and hemorrhage. Differential diagnosis w Peptic ulcer disease w hepatic cirrhosis w gastric carcinoma Treatment 1. Removal of the causes • avoidance and discontinuance of the administration of NSAIDs and ethanol • effective treatment of severe diseases 2. prevention and treatment • reduce gastric acid . • Neutralizing gastric acid(antacids) – colloidal alumiun hydroxid, NaHCO3 • reducing gastric acid secretion H2RA PPI • Protect mucose : prostaglandin 3. management of gastric bleeding : ①general treatment:bed rest liquid diet overview and surveille ②blood volume supplement:fluid infusion、blood transfusion—first elect ③stop bleeding:anti acid medicine endoscopic hemostasis surgery CHRONIC GASTRITIS Introduction • Chronic gastritis main refer to chronic inflammation of gastric mucosa caused by H.pylori and involves inflammatory changes in the mucosa • Is a very common disease. • The inflammation cells in chronic gastritis are mainly lymphocytes and plasma cells,and there may be a few of neutrophils and eosinophils. • The inflammatory changes are usually patchily distributed . In late stage atrophy and metaplasia can be found in the gastric mucosa . Epidemiology w Prevalence : >50% w H.pylori: in population ,the infection rate is 40%-70% in chronic gastritis, the infection rate is 87% Classification w There are many classifications: • Whitehead(1972): • superficial gastritis • atrophic gastritis • Strikland (1973) :According to the anatomic portion predominantly involved , atrophic gastritis is classified : • type A( body gastritis) • type B( antral gastritis) • Misiewicz and Tytgat (1990): Sydney System • 1996: Updated Sydney System • non-atrophic gastritis atrophic gastritis special gastritis etiology and mechanism w H.pylori infection • A gram-negative bacterium • a quite strong infective ability • incidence is very high. • It is estimated that 50% of the population over the age of 50 years are infected with H.pylori in developed countries. • The H.pylori infective rate is 80%-95% in the chronic gastritis H. pylori • Stay in gastric antrum, lives in the gastric crypts, gastric metaplasia (duodenal bulb) w Mechanism • H. pylori have the ability to produce a wide variety of virulence factors. • Most H.pylori associated gastritis dose not develop to erosions,but the inflammation can progress to depth of the mucosa and lead to atrophy. w Autoimmunity and heredity • autoantibody in the blood : parietal cell antibody, PCA; intrinsic factor antibody, IFA • autoimmune disease: accompaniment Hashimoto thyroiditis; vitiligo w Other factors : • duodenal juice(Bile and pancreatic juice) reflux • damage gastric mucosa factors: NSAID, alcohol abuse pathology w H.pylori infection w inflammation :The inflammation cells in chronic gastritis are mainly lymphocytes and plasma cells w activity: Classified phase • static phase: • the predominant inflammatory cells in chronic gastritis are lymphocytes and plasma cells ,and this kind of inflammatory conditions is called “static phase” • active phase: • there are predominant collections of neutrophils and eosinaphils free in the lamina propria and in the lining epithelium ,this condition is called “active phase” w atrophic gastritis • atrophic gastritis is characterized by a variable glands loss and encroachment of inflammatory cells into the gland zones. w Metaplasia • intestinal metaplasia : goblet cell • pseudopyloric gland metaplasia w dysplasia • moderate and severe dysplasia is considered to be possible precancerous conditions atrophia inflammation metaplasia Clinical manifestation symptoms : dyspepsia signs : without; or lightly tenderness in epigastrium Others: anore
展开阅读全文

开通  VIP会员、SVIP会员  优惠大
下载10份以上建议开通VIP会员
下载20份以上建议开通SVIP会员


开通VIP      成为共赢上传

当前位置:首页 > 管理财经 > 管理学资料

移动网页_全站_页脚广告1

关于我们      便捷服务       自信AI       AI导航        抽奖活动

©2010-2026 宁波自信网络信息技术有限公司  版权所有

客服电话:0574-28810668  投诉电话:18658249818

gongan.png浙公网安备33021202000488号   

icp.png浙ICP备2021020529号-1  |  浙B2-20240490  

关注我们 :微信公众号    抖音    微博    LOFTER 

客服